Post Profile

Teva Releases First Breath Activated Asthma Inhaler in U.S.

Traditional corticosteroid inhalers for management of asthma symptoms require patients to squeeze and inhale in a coordinated maneuver. This is surprisingly difficult for many patients who end up receiving sub-optimal treatment. Teva Pharmaceutical, Israel’s big pharma firm, is now releasing in the RediHaler, the first breath-activated corticosteroid inhaler available in the U.
read more


Related Posts

Single Combined Asthma Inhaler Better Than Recommended Treatment

Health : Medical News Today

Using two asthma medications combined in a single inhaler provides superior rescue and preventive treatment than guideline-based treatments among adults whose asthma symptoms are not well controlled, according to two large, randomiz...

Long-Term Inhaled Corticosteroid Use Increases Fracture Risk in Lung Disease Patients

Health : Newswise Medical News

Patients with chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids to improve breathing for more than six months have a 27 percent increased risk of bone fractures, new Johns Hopkins-led research suggests.

Older Asthma Patients at Increased Risk for Treatment Failure

Health : Newswise Medical News

Older patients with asthma are at increased risk for treatment failure, particularly those patients being treated with inhaled corticosteroids, according to a new study.

Combination Formoterol And Budesonide As Maintenance And Reliever Therapy Vs Inhaled Steroid Maintenance For Chronic Asthma In Adults And Children

Health : Medical News Today

Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy. The combination of formoterol and budesonide in a single inhaler introduces the possibility of using a single inhaler for both prevent...

Research Finds Little Difference in Outcomes Among Strategies to Adjust Asthma Therapy

Health : Newswise Medical News

Among adults with asthma controlled with low-dose inhaled corticosteroid therapy, the time to treatment failure was not significantly different among patients who received corticosteroid dose adjustment based on physician assessment...


Copyright © 2016 Regator, LLC